Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours

Based on the already known in vitro synergy between paclitaxel (taxol), cisplatin and oxazophosphorine cytostatics and the broad spectrum of activity of the above drugs we sought to evaluate the paclitaxel (taxol)-ifosfamide-cisplatin (PIC) combination in the outpatient setting in individuals with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, C, Tsavaris, N B, Polyzos, A, Malamos, N A, Katsikas, M, Antonopoulos, M J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363298/
https://www.ncbi.nlm.nih.gov/pubmed/10646881
http://dx.doi.org/10.1054/bjoc.1999.0919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363298/
https://www.ncbi.nlm.nih.gov/pubmed/10646881
http://dx.doi.org/10.1054/bjoc.1999.0919

Ejemplares similares